THE MOST ADVANCED TREATMENT CONCEPTS

Precision-Based Medicine — Personalized Cancer Therapy at the Hallwang Clinic

The Hallwang Clinic combines cutting-edge genomic diagnostics with evidence-based oncology. Discover how precision medicine leads to individualized treatment strategies and improved clinical outcomes.

In modern oncology, precision medicine means understanding cancer at its core — and treating it accordingly. At the Hallwang Clinic, advanced diagnostics and the latest scientific insights are used to develop personalized therapies tailored to each patient.

Instead of applying standardized protocols, our oncologists analyze the genetic, molecular, and immunological characteristics of each tumor to define a targeted treatment plan. This approach enhances therapeutic efficacy, reduces side effects, and promotes long-term quality of life.

Precision Medicine — A Defining Shift in Cancer Treatment 

Precision medicine is now widely recognized as a breakthrough in oncology. Leading medical societies view personalized, molecularly guided therapies as a cornerstone of modern cancer care.

The European Society for Medical Oncology (ESMO) strongly recommends the use of next-generation sequencing (NGS) and molecular tumor boards for advanced solid tumors — enabling clinicians to identify actionable mutations and therapeutic targets (Annals of Oncology, 2024).

Likewise, the American Society of Clinical Oncology (ASCO) emphasizes the importance of integrating precision approaches into routine cancer care (ASCO, 2023). Scientific studies confirm that comprehensive genomic profiling (CGP) significantly increases therapy response rates and improves survival.

The Hallwang Clinic applies these insights directly to clinical care. Our team interprets molecular and immunological data in real time and translates findings into highly individualized treatment decisions — combining scientific excellence with clinical precision.

Precise Diagnostics as the Foundation of Every Treatment Decision 

The first goal of any precision-based therapy is clear: to understand the tumor biologically. Only then can we determine which medications, immunotherapies, or combinations make medical sense. The Hallwang Clinic therefore follows a multi-step molecular diagnostics protocol:

• Genomic Profiling (GP): We analyze tumor DNA to detect mutations, drivers, and signaling pathways. This helps determine whether a cancer may respond to EGFR-, BRAF-, ALK-, or HER2-targeted therapies.
• Liquid Biopsy: We examine circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) from a simple blood sample — even when no recent tissue sample is available. This also enables us to monitor treatment response over time.
• Tumor-Associated Antigen Screening (TAA): We identify tumor-associated antigens and immune-relevant targets to determine whether the immune system can be directed against specific tumor surfaces.
• Tumor Mutational Burden (TMB): We assess the tumor’s mutational load to evaluate the likelihood of response to immune checkpoint inhibitors.
• Chemosensitivity and Resistance Testing: We test, in vitro, which cytotoxic or targeted agents a tumor is most sensitive to — and which it may already resist.

These results not only reveal what drives the tumor but also where we can intervene therapeutically. Based on this data, we create not a theoretical recommendation, but a real-world treatment plan.

From Analysis to Personalized Therapy 

Once all diagnostic data has been reviewed, our interdisciplinary team develops a coordinated treatment plan. We don’t think in isolated measures — we assemble therapeutic building blocks that work together synergistically.

Our focus areas include:

• Immunotherapies: Including checkpoint inhibitors, CAR-T cell therapy, antibody-drug conjugates (ADCs), and multifunctional antibody strategies — designed to activate and direct the immune system with precision. Learn more about immunotherapies at the Hallwang Clinic here.
• Targeted Therapies: We select drugs that specifically block the mutations or growth signals we’ve identified — treating not just “cancer in general” but this patient’s specific tumor biology.
• Metabolic and Anti-Angiogenic Therapies: By disrupting tumor metabolism and blood supply, we enhance the impact of immune and antibody-based treatments.
• Integrative Therapies: Including hyperthermia, hyperbaric oxygen therapy, and ozone therapy — to improve circulation, tissue regeneration, and immune resilience.

This approach merges precision-based science with attentive, personal care. We don’t just plan treatment — we guide it, monitor outcomes, adjust dosages, manage resistance, and prioritize the patient’s overall condition throughout.

Interdisciplinary Expertise and Global Collaboration 

The Hallwang Clinic is one of the leading oncology centers focused on precision and immuno-oncology. Each case is managed by a team of board-certified oncologists and specially trained oncology nurses. Complex cases are discussed in internal tumor boards — and if needed, external experts from our international network are consulted.

Our collaborations with renowned university laboratories and research institutions give us access to diagnostic tools and therapies not widely available in all healthcare systems. These partnerships help us ensure that each treatment strategy is not only guideline-compliant, but also advanced and individually tailored.

Holistic Cancer Medicine — With Precision and Compassion 

To us, precision medicine is not purely technical. A patient needs more than the right drug — they need a body capable of supporting therapy. That’s why we complement treatment plans with integrative and supportive care options.

Our patients benefit from: 

• Nutritional medicine to stabilize metabolism and reduce inflammation 
• Psycho-oncological support to address anxiety, fatigue, and uncertainty 
• Movement and relaxation programs to improve circulation and reduce cancer-related fatigue 
• Complementary therapies based on natural medicine — always as supportive, never as a replacement for evidence-based oncology

This combined approach strengthens the patient’s capacity to undergo treatment — not just fighting the disease, but building resilience. It’s this fusion of high-performance medicine and human connection that defines the Hallwang model.

Ongoing Support and Long-Term Care 

Our responsibility doesn’t end when patients leave the clinic. We continue to support them throughout their treatment journey — including after they return home or transition to local care.

To this end, we maintain 24/7 communication channels for patients and referring physicians — for lab reviews, imaging updates, or quick medical input on side effects. When adjustments are needed, we respond rapidly and with coordinated care.

This close follow-up is especially vital for patients with metastatic or rapidly progressing disease. They know the Hallwang team is always engaged. This relationship of trust is a critical component of therapeutic success.

Frequently Asked Questions About Precision Oncology

Your Path to Personalized Cancer Care

The satisfaction and trust of our patients are our highest priority. We take your diagnosis — and your life circumstances — seriously and adapt treatment accordingly.

If you want to explore whether a precision-based approach is right for your condition, contact us. We’ll take time to evaluate your case — even if it’s complex or has exhausted options elsewhere.